Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 11:08 AM
Ignite Modification Date:
2025-12-26 @ 11:08 AM
NCT ID:
NCT02419612
Eligibility Criteria:
For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com
Inclusion Criteria:
* Subjects must be willing and able to give signed and dated written informed consent
* Patients with Type 2 diabetes mellitus (T2DM) with inadequate glycemic control
* Subjects should have been taking the same daily dose of metformin ≥ 1500 mg
* Fasting Plasma Glucose ≤ 270 mg/dL (≤15 mmol/L)
* Males and females, aged ≥18 years old at time of screening visit
* Women of childbearing potential (WOCBP) must have a negative serum or urine pregnancy test
* WOCBP and males must agree to follow instructions for method(s) of contraception for the duration of treatment with study drug
Exclusion Criteria:
* Clinical diagnosis of type I diabetes
* History of diabetic ketoacidosis
* Cardiovascular/vascular diseases within 3 months of the enrollment
* Renal disease
* Hepatic diseases
* History of, or currently, acute or chronic pancreatitis
* Hematological and oncological disease/conditions
* Patients who have contraindications to therapy being studied
* Patients on weight loss program(s)
* Replacement or chronic systemic corticosteroid therapy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
120 Years
Study:
NCT02419612
Study Brief:
Protocol Section:
NCT02419612